⌘K

Login Start Free

Home/Filings/4/0001735276-18-000028

4//SEC Filing

CLARKE JOHN K 4

Accession 0001735276-18-000028

CIK 0001178670other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 4:18 PM ET

Size

4.9 KB

Accession

0001735276-18-000028

Insider Transaction Report

Form 4

Period: 2018-06-20

ALNYLAM PHARMACEUTICALS, INC.ALNY

Director

Transactions

Award
Stock Option (right to buy)
2018-06-20+9,000→ 9,000 total
Exercise: $105.26From: 2019-06-20Exp: 2028-06-19→ Common Stock (9,000 underlying)

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

Entity typeother

Related Parties

1

filerCIK 0001219015

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 4:18 PM ET
Size: 4.9 KB

View on SEC.gov